Catalyst Wire Dossier Catalyst Wire Dossier

Insulin 287 (NNC0148-0287 C)

NNC0148-0287 C · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Insulin 287 (NNC0148-0287 C), covering 2024-07-12 to 2024-07-12. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study of How a New Medicine NNC0148-0287 C (Insulin 287) Works in the Body of People With Kidney Problems [Phase 1]

See pricing